TMS-induced Plasticity Improving Cognitive Control in OCD

  • STATUS
    Recruiting
  • End date
    Nov 24, 2022
  • participants needed
    75
  • sponsor
    VU University Medical Center
Updated on 24 January 2021
behavior therapy
transcranial magnetic stimulation
cognitive therapy
brain stimulation

Summary

Repetitive transcranial magnetic stimulation (rTMS) has been shown in several previous clinical trials to be an effective treatment for obsessive-compulsive disorder (OCD). However, the neural working mechanisms of rTMS in OCD are unknown, and the optimal stimulation sites have not yet been established. Our study aims to compare the clinical and neurobiological effects of three different rTMS stimulation protocols in OCD patients. 8 weeks of rTMS therapy will be delivered in combination with cognitive behavioural therapy. Multimodal neuroimaging will be carried out before and after treatment in order to demonstrate the neurobiological effects of the therapy.

Details
Condition Obsessive-Compulsive Disorder, ANXIETY NEUROSIS, Anxiety Disorders, Generalized Anxiety Disorder (GAD), Anxiety Disorders (Pediatric), Generalized Anxiety Disorder (GAD - Pediatric), Anxiety Disorders (Pediatric), Generalized Anxiety Disorder (GAD), Generalized Anxiety Disorder (GAD - Pediatric), Anxiety Disorders, obsessive compulsive disorder
Treatment Repetitive transcranial magnetic stimulation
Clinical Study IdentifierNCT03667807
SponsorVU University Medical Center
Last Modified on24 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

OCD patients
Age between 18 and 65
Primary DSM-5 diagnosis of OCD
Moderate to severe OCD symptoms (expressed as a minimum score of 16 on the Yale - Brown Obsessive Compulsive Scale (YBOCS)
Unmedicated or stable dose of medication for at least 12 weeks prior to randomisation
with no plans to change dose during the study period
At least 1 previous attempt at cognitive behavioural therapy (CBT) in lifetime
At least 1 previous attempt with serotonergic medication or strong preference for non-pharmacological treatment
Capacity to provide informed consent
Healthy controls (baseline measurements only)
Age between 18 and 65
Capacity to provide informed consent

Exclusion Criteria

OCD patients
MRI exclusion criteria (metal in body, pregnancy)
TMS exclusion criteria (metal in body, history of epilepsy)
Schizophrenia, bipolar disorder, active suicidal ideation, use of antipsychotics within last 12 weeks
previous experience with rTMS as treatment
Healthy controls
Current Diagnostic and Statistical Manual (DSM)-5 diagnosis
Personal history of DSM-5 diagnosis
use of psychotropic medications within last 12 months
st degree family member with OCD
MRI exclusion criteria (as above)
TMS exclusion criteria (as above)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note